NPR’s Shots blog examines the reemergence of tuberculosis in some parts of the world as well as the history of the disease, including in the U.S., as part of its continued coverage on the disease. “TB is not at all treated with the diligence that it should be,” Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development (TB Alliance), tells the blog (Doucleff, 7/19).